SCHEMBL8990052

SCHEMBL8990052

NC(=O)CSCCc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.62
MMP12 P39900 1/20 0.62
MMP13 P45452 1/20 0.62
CYP2C19 P33261 3/20 0.55
CYP1A2 P05177 2/20 0.55
CYP2D6 P10635 2/20 0.55
CA2 P00918 1/20 0.53
NOS1 P29475 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.49
ALPL P05186 1/20 0.49
ALPI P09923 1/20 0.49
ALPG P10696 1/20 0.49
HTT P42858 1/20 0.49
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
KEAP1 Q14145 1/20 0.48
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
HSD17B10 Q99714 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4574068 0.85 MMP12 (0.82) CES1MMP12MMP13CYP2C19CYP1A2
SCHEMBL4867754 0.82 CES1 (0.61) CES1MMP12MMP13CYP2C19CYP1A2
SCHEMBL1478837 0.81 MEN1 (0.66) CYP2C19CA2NOS1SMN1; SMN2LMNA
SCHEMBL20707338 0.80 ALDH1A1 (0.63) CES1MMP12MMP13CYP2C19CYP1A2
Hydrochloric Acid SCHEMBL5506583 0.79 MEN1 (0.63) CYP2C19CA2NOS1SMN1; SMN2MAPT
Bromide SCHEMBL3375119 0.79 MEN1 (0.63) CYP2C19CA2NOS1SMN1; SMN2LMNA
Carbamic Acid SCHEMBL2222080 0.77 FFAR1 (0.62) CES1NOS1SMN1; SMN2KEAP1LMNA
Urea SCHEMBL2006220 0.77 FFAR1 (0.62) CES1NOS1SMN1; SMN2KEAP1LMNA
SCHEMBL6049236 0.77 NOS1 (0.64) CES1MMP12MMP13CYP2C19CYP1A2
SCHEMBL577806 0.77 CYP1A2 (0.76) CES1MMP12MMP13CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5563250-A Cleavable conjugates for the delivery and release of agents in native form NEORX CORPORATION (US) 1996-10-08 US disclosed
US-5141648-A Methods for isolating compounds using cleavable linker bound matrices NEORX CORPORATION (US) 1992-08-25 US disclosed
EP-0318948-B1 CLEAVABLE IMMUNOCONJUGATES FOR THE DELIVERY AND RELEASE OF AGENTS IN NATIVE FORM NEORX CORPORATION (US) 1992-08-19 EP disclosed
US-5017693-A Methods for introducing a sulfhydryl amino or hydroxyl groups to a compound NEORX CORPORATION (US) 1991-05-21 US disclosed
EP-0318948-A2 Cleavable immunoconjugates for the delivery and release of agents in native form NEORX CORPORATION (US) 1989-06-07 EP disclosed